For comments, suggestions
Created with Raphaël 2.1.0 31.08.2018 Filing date 10.02.2020 Validation fee payment 31.08.2020 (A1) Patent application published 20.01.2022 AGEPI application filing date 31.03.2022 (T2) Translation of the validated European patent 22.05.2025 31.08.2025 Valid until 01.09.2026 Renewal fee to be paid until 31.08.2038 Patent will expire on

Patent in force


(210)Number of the EPO application18768795
(220)Filing date of the EPO application2018.08.31
(80)EPO patent specification publication (B)EPB nr. 44/2021, 2021.11.03
(110)EPO patent number3675894
(11)Number of the documentMD 3675894 T2
(21)Number of the applicatione 2020 0700
(71)Name(s) of applicant(s), code of the countryFERRING B.V., NL;
(72)Name(s) of inventor(s), code of the countryARCE SAEZ Joan-Carles, DK;
HELMGAARD Lisbeth, DK;
KLEIN Bjarke Mirner, DK;
(73)Name(s) of owner(s), code of the countryFERRING B.V., NL;
(54)Title of the inventionComposition for controlled ovarian stimulation
(13)Kind-of-document code T2
(51)International Patent Classification A61K 38/24 (2006.01.01); A61P 15/08 (2006.01.01)
(19)CountryNL
(41)Date of publication of the application2020.08.31
(49)Date of publication of the translation of the validated European patent specification2022.03.31
(30)Priority17189119, 2017.09.01, EP
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/EP2018/073442, 2018.08.31
(87)International publicationWO 2019/043143, 2019.03.07
Up
/Inventions/details/3675894